Indications |
Oral Malignant neoplasms of the prostate Adult: As Na: 360-480 mg tid. Maintenance: 120-240 mg tid; may gradually reduce to 240 mg daily. Intravenous Malignant neoplasms of the prostate Adult: As Na: Initially, 600-1200 mg daily by slow IV Inj for 5-10 days followed by 300 mg daily for 10-20 days. Maintenance: 300-600 mg, reduce slowly over few mth from dosing 4 times/wk to once wkly. |
Contraindications |
Pregnancy. Hypersensitivity. |
Warnings / Precautions |
Cardiovascular disease, hepatic impairment. Slow infusion is not recommended. |
Adverse Reactions |
Nausea, fluid retention, arterial and venous thrombosis, impotence, gynecomastia, withdrawal bleeding, hypercalcaemia, bone pain. |
ATC Classification |
L02AA04 - fosfestrol ; Belongs to the class of estrogens. |
Available As |
|
Fosfestrol
Post Review about Fosfestrol Click here to cancel reply.
Fosfestrol Containing Brands
Fosfestrol is used in following diseases
Drug - Drug Interactions of Fosfestrol
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.